Galectin Therapeutics to Present at the 28th Annual ROTH Conference

Monday, March 7, 2016 9:00 PM UTC

NORCROSS, Ga., March 07, 2016 -- Galectin Therapeutics, Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, announces today Peter G. Traber, M.D., the Company’s president, chief executive officer and chief medical officer, will present at the 28^th Annual ROTH Conference on Monday, March 14th, 2016 at 4:00 p.m. Pacific time. The conference is being held at the Ritz-Carlton, Laguna Niguel in Dana Point, California from March 13-16, 2016.

The ROTH Conference presentation will be webcast, and may be found on the company’s website at www.galectintherapeutics.com. The webcast and presentation will be archived on the company's website for 90 days following the event.

About Galectin Therapeutics

Galectin Therapeutics is developing promising carbohydrate-based therapies for the treatment of fibrotic liver disease and cancer based on the Company's unique understanding of galectin proteins, which are key mediators of biologic function. Galectin seeks to leverage extensive scientific and development expertise as well as established relationships with external sources to achieve cost-effective and efficient development. The Company is pursuing a development pathway to clinical enhancement and commercialization for its lead compounds in liver fibrosis and cancer. Additional information is available at www.galectintherapeutics.com.

Contacts
Jack Callicutt, Chief Financial Officer
(678) 620-3186
[email protected]

LHA
Kim Golodetz
(212) 838-3777
[email protected]

Galectin Therapeutics and its associated logo is a registered trademark of Galectin Therapeutics Inc.

Editor's Picks

Breathing through your nose when you exercise may make your runs easier

Entrepreneurs are facing a mental health crisis — here's how to help them

Are fish oil supplements as healthy as we think? And is eating fish better?

Will AI kill our creativity? It could – if we don’t start to value and protect the traits that make us human

Does AI have a right to free speech? Only if it supports our right to free thought

How can I lower my cholesterol? Do supplements work? How about psyllium or probiotics?

Why we need to set limits on sperm donation

Aging with a healthy brain: How lifestyle changes could help prevent up to 40% of dementia cases

Seven techniques to avoid weight regain, approved by experts

Galectin Therapeutics to Present at the 28th Annual ROTH Conference

Editor's Picks

Welcome to EconoTimes